FDA Approves EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Macleods Pharmaceuticals Limited

Macleods Pharmaceuticals Limited received FDA approval on May 15, 2020, for the generic drug emtricitabine and tenofovir disoproxil fumarate (ANDA 203442), which is likely to intensify competition in the established HIV treatment market segment. This authorization supports access to affordable therapies and pressures generic pricing within the fixed-dose combination market as the patent for the brand-name reference product approaches its expiration.